1. Home
  2. NTST vs XNCR Comparison

NTST vs XNCR Comparison

Compare NTST & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NetSTREIT Corp.

NTST

NetSTREIT Corp.

N/A

Current Price

$17.39

Market Cap

2.0B

Sector

Real Estate

ML Signal

N/A

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$24.77

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NTST
XNCR
Founded
2019
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
NTST
XNCR
Price
$17.39
$24.77
Analyst Decision
Buy
Buy
Analyst Count
20
14
Target Price
$22.92
★ $31.42
AVG Volume (30 Days)
★ 1.1M
1.0M
Earning Date
10-26-2026
11-04-2026
Dividend Yield
★ 5.09%
N/A
EPS Growth
★ 150.00
65.36
EPS
★ 0.12
N/A
Revenue
★ $195,006,000.00
$125,576,000.00
Revenue This Year
$29.01
$14.05
Revenue Next Year
$18.49
N/A
P/E Ratio
$149.63
★ N/A
Revenue Growth
★ 19.79
13.65
52 Week Low
$17.02
$10.38
52 Week High
$22.47
$30.61

Technical Indicators

Market Signals
Indicator
NTST
XNCR
Relative Strength Index (RSI) 18.87 51.52
Support Level $17.10 $23.36
Resistance Level $17.88 $30.61
Average True Range (ATR) 0.43 1.03
MACD -0.07 -0.09
Stochastic Oscillator 0.80 55.23

Price Performance

Historical Comparison
NTST
XNCR

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: